StockWatch
·
HARSHA ENGINEERS · Q2 FY27 · THE VERDICT

Growth on Track, but Margins Are Slipping — the Capex Ramp Ahead

Q2 revenue grew 16.3% YoY, validating management's mid-to-high teens India guidance. But operating margin fell to 17%, a full 300 basis points below the 20–22% target. The quarter reveals the near-term cost of the ₹150+ Cr capex expansion underway.

Q2 FY27 resultsHARSHAHarsha Engineers International Ltd06 Nov 2026 · 6 min read
Consolidated Revenue

₹440.1 Cr

+16.3% YoY | −3.8% QoQ (seasonal)

Operating Margin

17.0%

Target 20–22% | Gap −300 bps

Net Profit

₹45.0 Cr

+23.6% YoY | PAT leverage 10.1%

India Segment (H1)

~+22% YoY

On track for mid-to-high teens FY27

The Q2 result lands like a paradox: top-line growth is running ahead of guidance (+16.3% YoY vs. FY27 guided 10–12% consolidated), yet management is cautious on H2, and margins have compressed hard from target. The reason is operational, not accounting — and it frames the next 12–15 months.

Where the margin went

India's core engineering business is robust: EBITDA margin 23.7% signals pricing power and volume scale. But the consolidated OPM of 17% reflects three headwinds that management partially disclosed and partially deferred. Solar segment (LSB subsidiary) contributed ₹11.9 Cr revenue at just 6.1% EBITDA margin — a 170 bps drag on blended EBITDA if scaled across the business. Capex interest is starting to flow: the ₹150+ Cr expansion (₹110 Cr Advantek, ₹100 Cr China brownfield) announced this quarter will incur depreciation and finance charges from Q3 FY27 onwards, before revenue uplift arrives (Q3/Q4 for Cage outsourcing, Q3 FY28 for China production). Metal price absorption is the third: brass prices (copper/zinc) rose 6 months; management passed through ~50% to customers, absorbing the rest — a mechanical margin brake that persists as long as volatility does.

EBITDA Margin Context, %
08.8517.726.5423.7India Engineering6.1Solar (LSB)17Blended OPM20FY27 Target
India core is strong; Solar and capex drag are the margin story. Blended OPM 300 bps below target.

Claims on the call vs. what holds up

Management's statements graded against Q2 delivery

India high-teens growth FY27 reaffirmed

Q2 consolidated +16.3% YoY; India segment ~22% H1 YoY per CFO

Supported

Margin 20–22% sustainable at longer horizon

Q2 OPM 17.0%; India core 23.7% but blended down by Solar/capex drag

Contradicted

Bushing & Stamping each targeting ~30% FY27 growth

Not visible in consolidated; claimed as forward-looking; no segment detail given

Unverified

Advantek guidance ₹140 Cr reaffirmed; PAT positive FY27

H1 loss ₹7 Cr; management now says H2 improvement, not yet positive

Overstated

Consolidated 10–12% FY27 guidance maintained

Q2 delivery +16.3% YoY — well above range; management cautious on H2 (China soft, Romania drag, seasonality)

On track, but caveats

What changed on this call

Material shifts from Q1 guidance
  • Capex accelerated: ₹50–80 Cr FY27 → ₹150+ Cr over 12–15 months (₹110 Cr Advantek, ₹100 Cr China brownfield; new capex interest burden starting Q3

  • Advantek PAT timing deferred: Prior call implied FY27 positive; now H2 inflection only. H1 loss ₹7 Cr vs prior zero expectation

  • Romania loss now flagged: Was vague prior; management now saying FY27 loss will be 'much lower' than FY26's ₹14 Cr, but didn't quantify. Analyst estimate ₹10–12 Cr

  • India growth reaffirmed: Mid-to-high teens; +22% H1 YoY (India segment) claimed vs prior 'high-teens' target. On track, not raised

  • New catalysts disclosed: Resourcing/outsourcing project (Europe/US) ₹75 Cr peak annual run-rate, commercial start Q3/Q4 FY27; Japan customer +28% H1 (windmill gearbox tailwind); large windmill bearing (16 MW) now in supply

The bull-bear ledger

  • India business validating mid-to-high teens growth reaffirmed; +22% H1 YoY execution strong

  • Japan customer +28% H1; windmill gearbox market (5–10 MW turbines globally) a structural tailwind

  • Bushing & Stamping new products launching; Bushing targeting INR 300 Cr (4-year), Stamping INR 150–200 Cr — both from strong demand bases

  • Resourcing outsourcing project (₹75 Cr peak) de-risks international revenue diversification; commercial start Q3/Q4

  • Working capital improving (135 days vs 139 days PY); cash generation supporting capex outflows

  • Q2 OPM 17% vs 20–22% target is a material miss; near-term margin recovery unclear

  • Solar segment drag (6.1% margin, 9% of revenue) and Advantek loss (₹7 Cr H1) weighing on consolidated EBITDA

  • Romania ₹10–12 Cr FY27 loss estimated (vs ₹14 Cr FY26); downsizing plan vague; contingent 1–2 quarters

  • China soft at 1% Q2 YoY; ₹100 Cr capex expansion in uncertain market is execution risk

  • Metal price absorption (50% pass-through, 50% absorbed) is margin headwind with no visibility to relief

  • Capex interest & depreciation burden starting Q3; near-term PAT pressure before commercialization revenue (Q3/Q4 FY27 for Cage, Q3 FY28 for China)

  • Management tone cautious on H2; guided consolidated 10–12% FY27 with caveats on seasonality, Romania, China softness — implies downside risk

How the street is positioned

Harsha closed 2026-11-05 at ₹468.45, up +49.52% from its 52-week low of ₹313.3 but still −23.69% below its all-time high of ₹613.85. The stock trades above its 20-day (₹435.55), 50-day (₹445.73), and 200-day (₹405.8) moving averages — a textbook bullish alignment — yet the drawdown from ATH and rising volume suggest selective conviction, not broad FOMO. RSI 61.3 indicates neutral momentum (not overbought; not oversold).

Institutional flows are mixed. FII ownership stands at 1.79%, down 58 bps QoQ; DII ownership rose to 13.02% (+59 bps QoQ), with promoters steady at 75%. The FII trim is telling: international investors are pulling back slightly even as the stock rallies — likely a signal that near-term margin pressure and capex execution risk are giving them pause. DII accumulation suggests domestic mutual funds and insurance are more comfortable holding through the capex ramp, betting on long-term capacity unlocking.

The chart reconciliation: the stock's bullish trend (above all MAs) reflects confidence in the long-term capex narrative — ₹150+ Cr expansion unlocking Bushing/Stamping 30% growth, resourcing ₹75 Cr ramp, renewables tailwind. But the −23.69% drawdown from ATH and FII trimming signal the market is pricing in 12–15 months of execution risk, margin pressure, and China/Romania uncertainty before the payoff arrives. This is not a "growth at any price" momentum play; it is a disciplined long-term bet with caution on the near-term.

Ranked risks for a holder

Concerns ordered by impact on near-term returns and long-term thesis

Romania loss containment & restructuring clarity

High

FY26 loss ₹14 Cr; FY27 estimated ₹10–12 Cr (mgmt deferred quantification). Downsizing scope and profitability timeline vague. If loss widens or restructuring costs materialize, PAT drag accelerates. Mgmt promised Q3 update; if delayed or unsatisfactory, confidence erodes.

Capex execution & commercialization timing

High

₹150+ Cr capex (₹110 Cr Advantek, ₹100 Cr China) over 12–15 months is aggressive. Customer approval delays possible; commercialization revenue (Q3/Q4 for Cage, Q3 FY28 for China) uncertain. Near-term cash burn before revenue uplift; if timeline slips or ramp is slower, ROIC and PAT recovery delayed.

Margin recovery trajectory unclear

High

Q2 OPM 17% vs 20–22% target is not a seasonal dip but structural. Solar drag, capex interest, metal absorption are persistent. If Q3/Q4 OPM stays ≤17%, or if capex interest further compresses to 16%, margin recovery thesis breaks. This is the number to track next quarter.

China market softness & capex risk

Medium

China Q2 growth only 1% YoY; soft demand signals execution risk. ₹100 Cr capex expansion in uncertain market. If China growth doesn't recover to 5–7% forward guidance, capex ROI compressed and timeline becomes a liability.

Metal price volatility & pass-through lag

Medium

50% absorption mechanism is a margin drain. If brass prices stay elevated or customer contracts resist further increases, margin recovery blocked. This is a macro headwind outside management control but visible in P&L.

Resourcing project commercialization & ramp risk

Low

₹75 Cr peak annual run-rate is aspirational; commercial start Q3/Q4 FY27 but ramp to peak is 12–24 months away. If customer approvals delay or volume uptake slower, revenue contribution deferred. But multiple projects in pipeline reduce single-project risk.

What to watch next

Concrete catalysts and data points for Q3 review
  • 1 · Operating margin trajectory in Q3 FY27

    Will OPM stay ≤17% or recover toward 18–19%? This is the linchpin: capex interest/depreciation will start flowing; Solar drag will persist. If Q3 OPM is 16% or below, margin recovery thesis is at risk. Track: India EBITDA margin sustainability, Solar profitability, capex interest quantum in P&L.

  • 2 · Romania downsizing scope & profitability timeline

    Management promised Q3 clarity on restructuring plan and FY27 loss quantum. If deferred again or loss estimate widens, confidence erodes. If concrete plan emerges (headcount reduction, capacity rationalization timeline), near-term pain is visible but manageable.

  • 3 · Resourcing project commercial traction

    Q3/Q4 FY27 commercial sales start. Early revenue visibility and ramp trajectory will validate (or deflate) the ₹75 Cr peak run-rate claim and de-risk the international diversification story.

  • 4 · China capex execution pace & volume pipeline

    Is ₹100 Cr brownfield capex on track for Q3 FY28 production start? Any customer order visibility for 5–7% growth forward guidance? Soft Q2 (1%) needs evidence that recovery is coming.

  • 5 · Bushing & Stamping segment growth delivery

    Management targets 30% FY27 growth each; Q2 aggregate performance (Bushing +26% QoQ, Stamping +35% YoY) shows momentum. But is this on pace for full-year 30%, or is guidance inflation? Quarterly tracking will clarify.

  • 6 · Advantek profitability inflection in H2

    H1 loss ₹7 Cr; management expects H2 improvement and full-year PAT positive. Q3 result will signal whether the ramp is real or another timing miss.

The number to track from here

Operating Profit Margin (OPM). At 17%, it is 300 basis points below the 20–22% guidance. Recovery to 19–20% signals that capex/Solar drag is beginning to fade and that consolidated gross margin is improving. If OPM compresses further in Q3 (guidance 16% or below), the near-term margin-pressure thesis dominates, and re-rating downward becomes inevitable. If OPM expands back to 18.5%+ by Q4, the long-term capex thesis survives and holds credibility.

Harsha is a story of execution unfolding in two speeds: near-term (Q3–Q4 FY27) is a margin-pressure, capex-ramp quarter; long-term (FY28+) is a capacity-expansion, 30%+ growth, renewables-tailwind narrative. The result validates growth (India +22% H1, reaffirmed mid-to-high teens FY27) but challenges margins (OPM 17% vs. 20–22% target). Management has shown decisiveness on capex acceleration and transparency on India segment, but tone is cautious and credibility is slightly dented on Advantek profitability and Romania loss timing.

The market's position (stock above all moving averages, but −23.69% from ATH, FII trimming) reflects this duality: bullish on the long-term, cautious on the near-term. For holders, this is a Hold pending Q3 capex/margin clarity. For fresh entry, wait for better prices (₹430–440) or Q3 evidence that margin recovery is real. The thesis survives — but the near-term is not free. Watch the OPM.

Informational and educational content only. Not investment advice.